ADAriane Do

Ariane Do

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Ariane Do has a total of 16 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Inflammatory low back pain with radiculopathy revealing epidural disintegration of a bullet complicated by lead poisoning

    by Ariane Do, Lorenzo Garzelli, Robert Garnier, Charles Court, Jérémie Sellam, Anne Miquel, Francis Berenbaum

    Inflammatory low back pain with radiculopathy is suggestive of cancer, infection or inflammatory diseases. We report a unique case of a 42-year-old patient with an acute inflammatory low back pain with bilateral radiculopathy associated with weight loss and abdominal pain, revealing the disintegration of a lead bullet along the epidural space and the S1 nerve root complicated by lead poisoning. Because of the high blood lead level of intoxication (>10 times over the usual lead levels) and the failure of repeated lead chelator cycles, a surgical treatment to remove bullet fragments was performed. It resulted in a significant decrease of pain and lead intoxication.


  • Open Access

    The Role of the Non‐neuronal Cholinergic System in Inflammation and Degradation Processes in Osteoarthritis

    by Alice Courties, Ariane Do, Sarah Leite, Manon Legris, Laure Sudre, Audrey Pigenet, Juliette Petit, Geoffroy Nourissat, Adeline Cambon‐Binder, Uwe Maskos, et al.

    Objective: The non‐neuronal cholinergic system represents non‐neuronal cells that have the biochemical machinery to synthetize de novo and/or respond to acetylcholine (ACh). We undertook this study to investigate this biochemical machinery in chondrocytes and its involvement in osteoarthritis (OA).Methods: Expression of the biochemical machinery for ACh metabolism and nicotinic ACh receptors (nAChR), particularly α7‐nAChR, in human OA and murine chondrocytes was determined by polymerase chain reaction and ligand‐binding. We investigated the messenger RNA expression of the human duplicate α7‐nACh subunit, called CHRFAM7A, which is responsible for truncated α7‐nAChR. We assessed the effect of nAChR on chondrocytes activated by interleukin‐1β (IL‐1β) and the involvement of α7‐nAChR using chondrocytes from wild‐type (WT) and α7‐deficient Chrna7−/− mice. The role of α7‐nAChR in OA was explored after medial meniscectomy in WT and Chrna7−/− mice.Results: Human and murine chondrocytes express the biochemical partners of the non‐neuronal cholinergic system and a functional α7‐nAChR at their cell surface (n = 5 experiments with 5 samples each). The expression of CHRFAM7A in human OA chondrocytes (n = 23 samples) correlated positively with matrix metalloproteinase 3 (MMP‐3) (r = 0.38, P < 0.05) and MMP‐13 (r = 0.48, P < 0.05) expression. Nicotine decreased the IL‐1β–induced IL‐6 and MMP expression, in a dose‐dependent manner, in WT chondrocytes but not in Chrna7−/− chondrocytes. Chrna7−/− mice that underwent meniscectomy (n = 7) displayed more severe OA cartilage damage (mean ± SD Osteoarthritis Research Society International [OARSI] score 4.46 ± 1.09) compared to WT mice that underwent meniscectomy (n = 9) (mean ± SD OARSI score 3.05 ± 0.9; P < 0.05).Conclusion: The non‐neuronal cholinergic system is functionally expressed in chondrocytes. Stimulation of nAChR induces antiinflammatory and anticatabolic activity through α7‐nAChR, but the anticatabolic activity may be mitigated by truncated α7‐nAChR in human chondrocytes. In vivo experiments strongly suggest that α7‐nAChR has a protective role in OA.